Voyager Therapeutics (VYGR) Competitors $2.96 -0.23 (-7.21%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$3.06 +0.10 (+3.21%) As of 08/1/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock VYGR vs. MGTX, PHAR, TLRY, STOK, DNTH, GYRE, DNA, DAWN, XNCR, and AUTLShould you be buying Voyager Therapeutics stock or one of its competitors? The main competitors of Voyager Therapeutics include MeiraGTx (MGTX), Pharming Group (PHAR), Tilray Brands (TLRY), Stoke Therapeutics (STOK), Dianthus Therapeutics (DNTH), Gyre Therapeutics (GYRE), Ginkgo Bioworks (DNA), Day One Biopharmaceuticals (DAWN), Xencor (XNCR), and Autolus Therapeutics (AUTL). These companies are all part of the "pharmaceutical products" industry. Voyager Therapeutics vs. Its Competitors MeiraGTx Pharming Group Tilray Brands Stoke Therapeutics Dianthus Therapeutics Gyre Therapeutics Ginkgo Bioworks Day One Biopharmaceuticals Xencor Autolus Therapeutics MeiraGTx (NASDAQ:MGTX) and Voyager Therapeutics (NASDAQ:VYGR) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, risk, institutional ownership, media sentiment, valuation, dividends and profitability. Which has more volatility & risk, MGTX or VYGR? MeiraGTx has a beta of 1.25, meaning that its stock price is 25% more volatile than the S&P 500. Comparatively, Voyager Therapeutics has a beta of 0.9, meaning that its stock price is 10% less volatile than the S&P 500. Which has better valuation & earnings, MGTX or VYGR? Voyager Therapeutics has higher revenue and earnings than MeiraGTx. MeiraGTx is trading at a lower price-to-earnings ratio than Voyager Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMeiraGTx$33.28M18.47-$147.79M-$2.32-3.30Voyager Therapeutics$80M2.05-$65M-$1.46-2.03 Do analysts recommend MGTX or VYGR? MeiraGTx presently has a consensus price target of $24.00, suggesting a potential upside of 213.73%. Voyager Therapeutics has a consensus price target of $13.39, suggesting a potential upside of 352.36%. Given Voyager Therapeutics' stronger consensus rating and higher possible upside, analysts clearly believe Voyager Therapeutics is more favorable than MeiraGTx.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MeiraGTx 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Voyager Therapeutics 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 3.13 Do institutionals & insiders hold more shares of MGTX or VYGR? 67.5% of MeiraGTx shares are held by institutional investors. Comparatively, 48.0% of Voyager Therapeutics shares are held by institutional investors. 7.5% of MeiraGTx shares are held by insiders. Comparatively, 6.4% of Voyager Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Is MGTX or VYGR more profitable? Voyager Therapeutics has a net margin of -126.49% compared to MeiraGTx's net margin of -484.90%. Voyager Therapeutics' return on equity of -27.36% beat MeiraGTx's return on equity.Company Net Margins Return on Equity Return on Assets MeiraGTx-484.90% -241.05% -62.93% Voyager Therapeutics -126.49%-27.36%-21.06% Does the media prefer MGTX or VYGR? In the previous week, Voyager Therapeutics had 2 more articles in the media than MeiraGTx. MarketBeat recorded 3 mentions for Voyager Therapeutics and 1 mentions for MeiraGTx. Voyager Therapeutics' average media sentiment score of 0.77 beat MeiraGTx's score of 0.00 indicating that Voyager Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MeiraGTx 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Voyager Therapeutics 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryVoyager Therapeutics beats MeiraGTx on 13 of the 17 factors compared between the two stocks. Get Voyager Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VYGR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VYGR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VYGR vs. The Competition Export to ExcelMetricVoyager TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$176.52M$3.00B$5.48B$9.52BDividend YieldN/A2.43%4.73%4.08%P/E Ratio-2.0317.6228.6723.80Price / Sales2.05178.97373.5466.64Price / CashN/A41.9535.4557.96Price / Book0.548.508.275.55Net Income-$65M-$55.06M$3.24B$259.03M7 Day Performance-8.64%-3.98%-3.69%-4.59%1 Month Performance-7.50%9.59%4.33%4.46%1 Year Performance-64.34%6.72%25.95%18.03% Voyager Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VYGRVoyager Therapeutics4.1156 of 5 stars$2.96-7.2%$13.39+352.4%-65.9%$176.52M$80M-2.03100Upcoming EarningsMGTXMeiraGTx4.135 of 5 stars$8.69+0.8%$24.00+176.2%+56.8%$698.33M$33.28M-3.75300PHARPharming Group3.0169 of 5 stars$10.14-1.0%$30.00+195.7%+43.1%$694.97M$297.20M-50.72280News CoveragePositive NewsEarnings ReportGap DownTLRYTilray Brands2.8903 of 5 stars$0.67+8.4%$1.92+184.6%-71.4%$677.88M$788.94M-0.642,650Trending NewsEarnings ReportAnalyst ForecastInsider TradeAnalyst RevisionGap DownSTOKStoke Therapeutics4.0299 of 5 stars$12.31-6.9%$25.80+109.6%-12.3%$672.13M$36.56M15.58100Upcoming EarningsDNTHDianthus Therapeutics1.2237 of 5 stars$20.74+1.7%$53.00+155.5%-26.5%$667.00M$6.24M-7.2080Upcoming EarningsGYREGyre TherapeuticsN/A$7.10-1.5%N/A-52.4%$665.70M$105.76M355.1840DNAGinkgo Bioworks1.1775 of 5 stars$11.31+11.6%$8.50-24.8%N/A$661.68M$227.04M-1.23640News CoverageGap DownDAWNDay One Biopharmaceuticals2.2503 of 5 stars$6.40flat$29.00+353.1%-53.1%$648.70M$131.16M-9.0160Upcoming EarningsXNCRXencor3.4779 of 5 stars$9.10+1.4%$28.00+207.7%-59.9%$647.65M$110.49M-2.97280News CoverageUpcoming EarningsShort Interest ↑AUTLAutolus Therapeutics2.3438 of 5 stars$2.43+0.8%$9.32+283.5%-47.9%$646.72M$10.12M-2.76330Gap Down Related Companies and Tools Related Companies MeiraGTx Alternatives Pharming Group Alternatives Tilray Brands Alternatives Stoke Therapeutics Alternatives Dianthus Therapeutics Alternatives Gyre Therapeutics Alternatives Ginkgo Bioworks Alternatives Day One Biopharmaceuticals Alternatives Xencor Alternatives Autolus Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VYGR) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Voyager Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Voyager Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VYGR Stock Alerts